Evidence map›Paper›PMID 36828382›Full record

ArticleTomography (Ann Arbor, Mich.)2023

Evaluation of Apparent Diffusion Coefficient Repeatability and Reproducibility for Preclinical MRIs Using Standardized Procedures and a Diffusion-Weighted Imaging Phantom.

Dariya Malyarenko, Ghoncheh Amouzandeh, Stephen Pickup, Rong Zhou, Henry Charles Manning, Seth T Gammon, Kooresh I Shoghi, James D Quirk, Renuka Sriram, Peder Larson and 5 more

Abstract read
In one paragraph

Article in Tomography (Ann Arbor, Mich.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. The Next Frontier in Quantitative Co-Clinical Imaging to Advance Functional Precision Oncology.Clinical cancer research : an official journal of the American Association for Cancer Research · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Dariya MalyarenkoDepartment of Radiology, University of Michigan, Ann Arbor, MI 48109, USA.ORCID 0000-0003-0403-1501
Ghoncheh AmouzandehDepartment of Radiology, University of Michigan, Ann Arbor, MI 48109, USA.
Stephen PickupDepartment of Radiology, University of Pennsylvania, Philadelphia, PA 19104, USA.
Rong ZhouDepartment of Radiology, University of Pennsylvania, Philadelphia, PA 19104, USA.ORCID 0000-0003-4018-381X
Henry Charles ManningDepartment of Cancer Systems Imaging, The University of Texas MDACC, Houston, TX 77030, USA.
Seth T GammonDepartment of Cancer Systems Imaging, The University of Texas MDACC, Houston, TX 77030, USA.ORCID 0000-0001-8647-0975
Kooresh I ShoghiMallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, MO 63110, USA.
James D QuirkMallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, MO 63110, USA.
Renuka SriramUCSF Department of Radiology & Biomedical Imaging, San Francisco, CA 94158, USA.ORCID 0000-0003-3505-2479
Peder LarsonUCSF Department of Radiology & Biomedical Imaging, San Francisco, CA 94158, USA.ORCID 0000-0003-4183-3634
Michael T LewisBaylor College of Medicine, Houston, TX 77030, USA.ORCID 0000-0002-6330-4007
Robia G PautlerBaylor College of Medicine, Houston, TX 77030, USA.ORCID 0000-0001-7952-8526
Paul E KinahanDepartment of Radiology, University of Washington, Seattle, WA 98195, USA.
Mark MuziDepartment of Radiology, University of Washington, Seattle, WA 98195, USA.ORCID 0000-0002-8767-191X
Thomas L ChenevertDepartment of Radiology, University of Michigan, Ann Arbor, MI 48109, USA.

Funding

Washington University Center for Cellular ImagingP30CA091842 · NCI · WASHINGTON UNIVERSITY · PI TIMOTHY J. EBERLEIN · 2001 to 2026
$128.0M
Elimination of Instrumental Bias for Quantitative Diffusion Imaging in Clinical Oncology TrialsR01CA190299 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI MALYARENKO, DARIYA I. · 2015 to 2025
$6.4M
WASHINGTON UNIVERSITY CO-CLINICAL IMAGING RESEARCH RESOURCEU24CA209837 · NCI · WASHINGTON UNIVERSITY · PI Li Ding, Shunqiang Li · 2017 to 2026
$6.3M
Preclinical Imaging XNAT-enabled Informatics (PIXI) CenterU24CA253531 · NCI · WASHINGTON UNIVERSITY · PI Daniel Scott Marcus, Kooresh Isaac Shoghi · 2020 to 2026
$5.1M
Quantitative DW-MRI for Early Breast Cancer Treatment Response AssessmentU01CA166104 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CHENEVERT, THOMAS L, GALBAN, CRAIG J · 2012 to 2019
$4.1M
Preclinical imaging characterization and resource development of PDX SCNC prostate cancer murine modelsU24CA253377 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KURHANEWICZ, JOHN, PEEHL, DONNA M. · 2020 to 2024
$3.4M
VU PREDICTU24CA220325 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI KOPETZ, SCOTT, MANNING, HENRY CHARLES · 2018 to 2022
$3.3M
INTEGRATING OMICS AND QUANTITATIVE IMAGING DATA IN CO-CLINICAL TRIALS TO PREDICT TREATMENT RESPONSE IN TRIPLE NEGATIVE BREAST CANCERU24CA226110 · NCI · BAYLOR COLLEGE OF MEDICINE · PI LEWIS, MICHAEL T., RUBIN, DANIEL L · 2019 to 2023
$3.2M
University of Michigan Quantitative Co-Clinical Imaging Research ResourceU24CA237683 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CHENEVERT, THOMAS L, LUKER, GARY D · 2019 to 2023
$3.1M
Penn Quantitative MRI Resource for Pancreatic CancerU24CA231858 · NCI · UNIVERSITY OF PENNSYLVANIA · PI ODWYER, PETER J, ROSEN, MARK ALAN · 2018 to 2022
$3.0M
A Quantitative PET/CT Research Resource for Co-Clinical Imaging of Lung Cancer TherapiesU24CA264044 · NCI · UNIVERSITY OF WASHINGTON · PI HOUGHTON, A MCGARRY, KINAHAN, PAUL E. · 2021 to 2025
$2.9M
Core Laboratory for Advanced PET and MRI image analysisR50CA211270 · NCI · UNIVERSITY OF WASHINGTON · PI Mark Muzi · 2017 to 2026
$2.6M
NCI NIH HHS P30 CA091842NCI NIH HHS R01 CA190299NCI NIH HHS R50 CA211270NCI NIH HHS U01 CA166104NCI NIH HHS U24 CA209837NCI NIH HHS U24 CA220325NCI NIH HHS U24 CA226110NCI NIH HHS U24 CA231858NCI NIH HHS U24 CA237683NCI NIH HHS U24 CA253377NCI NIH HHS U24 CA253531NCI NIH HHS U24 CA264044NIH HHS R01CA190299NIH HHS S10OD026912NIH HHS U01CA166104NIH HHS U24CA209837NIH HHS U24CA220325NIH HHS U24CA226110NIH HHS U24CA231858NIH HHS U24CA237683NIH HHS U24CA253377NIH HHS U24CA253531NIH HHS U24CA264044
6 · The paper itself

Abstract

Relevant to co-clinical trials, the goal of this work was to assess repeatability, reproducibility, and bias of the apparent diffusion coefficient (ADC) for preclinical MRIs using standardized procedures for comparison to performance of clinical MRIs. A temperature-controlled phantom provided an absolute reference standard to measure spatial uniformity of these performance metrics. Seven institutions participated in the study, wherein diffusion-weighted imaging (DWI) data were acquired over multiple days on 10 preclinical scanners, from 3 vendors, at 6 field strengths. Centralized versus site-based analysis was compared to illustrate incremental variance due to processing workflow. At magnet isocenter, short-term (intra-exam) and long-term (multiday) repeatability were excellent at within-system coefficient of variance, wCV [±CI] = 0.73% [0.54%, 1.12%] and 1.26% [0.94%, 1.89%], respectively. The cross-system reproducibility coefficient, RDC [±CI] = 0.188 [0.129, 0.343] µm

Indexed as

Diffusion Magnetic Resonance ImagingMagnetic Resonance ImagingBenchmarkingHumansPhantoms, ImagingReproducibility of ResultsADCADC biasapparent diffusion coefficientdiffusion phantompreclinical MRIrepeatabilityreproducibility

Identifiers

PMID36828382
PMCPMC9964373

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.